• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病患者血清激活素A水平与颈动脉内膜中层厚度的关联

The Association between the Activin A Serum Level and Carotid Intima-Media Thickness in Chronic Kidney Disease Patients.

作者信息

Yonata Ade, Ali Zulkhair, Indrajaya Taufik, Bahar Erial, Effendi Ian, Suhaimi Novadian, Suprapti Suprapti

机构信息

Department of Internal Medicine, Faculty of Medicine, Lampung University, Bandar Lampung 35141, Indonesia.

Department of Internal Medicine, Faculty of Medicine, Sriwijaya University, Palembang 30126, Indonesia.

出版信息

Int J Nephrol. 2020 Nov 9;2020:8893653. doi: 10.1155/2020/8893653. eCollection 2020.

DOI:10.1155/2020/8893653
PMID:33294228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7700056/
Abstract

INTRODUCTION

Chronic kidney disease (CKD) is associated with high mortality rates, mainly as a result of cardiovascular complications. Meanwhile, recent studies have suggested a role of a homodimer protein called activin A in chronic kidney disease-mineral and bone disorder (CKD-MBD) conditions that may exist in the vascular calcification and osteolytic process. Ultrasound examination of the carotid intima-media thickness (cIMT) is a noninvasive method to assess vascular calcification. This study aimed to analyze the relationship between the activin A serum level and cIMT in patients with CKD at Mohammad Hoesin Hospital, Palembang, Indonesia.

METHODS

We conducted a hospital-based, cross-sectional study of consecutive CKD patients at the Department of Internal Medicine, Mohammad Hoesin Hospital, from July to November 2019. The level of activin A was measured by enzyme-linked immunosorbent assay. Meanwhile, cIMT measurements were collected by -mode ultrasound imaging.

RESULTS

A total of 55 patients with CKD were included in this investigation. The median serum activin A level in these patients was 236.17 (116.33-283) pg/mL, while the median cIMT was 0.8 (0.6-1.45) mm. A relationship between the serum activin A level and cIMT (  =  0.449; = 0.001) was observed. During multivariate analysis with linear regression, triglyceride ( = 0.049), phosphate ( = 0.005), and activin A ( = 0.020) serum levels were factors associated with cIMT.

CONCLUSION

In this study, a relationship between the activin A serum level and cIMT in patients with CKD was identified. Vascular calcification should be screened for in all CKD patients by the measurement of cIMT.

摘要

引言

慢性肾脏病(CKD)与高死亡率相关,主要是心血管并发症所致。同时,近期研究表明,一种名为激活素A的同二聚体蛋白在慢性肾脏病 - 矿物质和骨代谢紊乱(CKD - MBD)中发挥作用,该紊乱可能存在于血管钙化和骨溶解过程中。颈动脉内膜中层厚度(cIMT)的超声检查是评估血管钙化的一种非侵入性方法。本研究旨在分析印度尼西亚巨港穆罕默德·霍辛医院CKD患者血清激活素A水平与cIMT之间的关系。

方法

我们于2019年7月至11月在穆罕默德·霍辛医院内科对连续性CKD患者进行了一项基于医院的横断面研究。激活素A水平通过酶联免疫吸附测定法测量。同时,通过B型超声成像收集cIMT测量值。

结果

本研究共纳入55例CKD患者。这些患者血清激活素A水平的中位数为236.17(116.33 - 283)pg/mL,而cIMT的中位数为0.8(0.6 - 1.45)mm。观察到血清激活素A水平与cIMT之间存在相关性(r = 0.

相似文献

1
The Association between the Activin A Serum Level and Carotid Intima-Media Thickness in Chronic Kidney Disease Patients.慢性肾脏病患者血清激活素A水平与颈动脉内膜中层厚度的关联
Int J Nephrol. 2020 Nov 9;2020:8893653. doi: 10.1155/2020/8893653. eCollection 2020.
2
Serum fibroblast growth factor 23 levels do not correlate with carotid intima-media thickness in patients with chronic kidney disease.慢性肾病患者血清成纤维细胞生长因子23水平与颈动脉内膜中层厚度不相关。
Saudi J Kidney Dis Transpl. 2019 Sep-Oct;30(5):1010-1021. doi: 10.4103/1319-2442.270255.
3
Nontraditional cardiovascular biomarkers and estimation of cardiovascular risk in predialysis chronic kidney disease patients and their correlations with carotid intima media thickness.非传统心血管生物标志物与透析前慢性肾脏病患者心血管风险评估及其与颈动脉内膜中层厚度的相关性
Nephrourol Mon. 2014 Nov 11;6(6):e22112. doi: 10.5812/numonthly.22112. eCollection 2014 Nov.
4
Association of Estimated GFR (By MDRD) with the Carotid Intima Media Thickness (CIMT) in Different Stages of CKD among Patients with Type 2 Diabetes Mellitus.2型糖尿病患者慢性肾脏病不同阶段估算肾小球滤过率(采用MDRD公式)与颈动脉内膜中层厚度(CIMT)的相关性
Mymensingh Med J. 2020 Jan;29(1):209-214.
5
Exploring the Relationship Between Serum Phosphate Levels and Carotid Intima-Media Thickness in Chronic Kidney Disease Patients: A Correlational Analysis.探索慢性肾脏病患者血清磷酸盐水平与颈动脉内膜中层厚度之间的关系:一项相关性分析。
Cureus. 2024 May 14;16(5):e60308. doi: 10.7759/cureus.60308. eCollection 2024 May.
6
Plasma activin A rises with declining kidney function and is independently associated with mortality in patients with chronic kidney disease.血浆激活素A水平随肾功能下降而升高,且与慢性肾病患者的死亡率独立相关。
Clin Kidney J. 2023 Sep 20;16(12):2712-2720. doi: 10.1093/ckj/sfad238. eCollection 2023 Dec.
7
Interleukin 6 concentration elevation as a risk of carotid intimamedia thickness in chronic kidney disease patients with dialysis.白细胞介素6浓度升高作为接受透析的慢性肾病患者颈动脉内膜中层厚度增加的一个风险因素。
Med Glas (Zenica). 2020 Aug 1;17(2):346-351. doi: 10.17392/1172-20.
8
Carotid intima-media thickness in children with CKD: results from the CKiD study.CKiD 研究中儿童的颈动脉内膜中层厚度。
Clin J Am Soc Nephrol. 2012 Dec;7(12):1930-7. doi: 10.2215/CJN.03130312. Epub 2012 Sep 13.
9
Association between Plasma Dehydroepiandrosterone Sulfate and Carotid Intima-Media Thickness among Male and Female Patients with End-Stage Renal Disease on Hemodialysis.血液透析终末期肾病男女性患者血浆硫酸脱氢表雄酮与颈动脉内膜中层厚度的相关性。
Cardiorenal Med. 2020;10(1):61-68. doi: 10.1159/000504083. Epub 2019 Nov 26.
10
The Relationship between Carotid and Femoral Artery Intima-Media Thickness and Histopathologic Grade of Atherosclerosis in Patients with Chronic Kidney Disease.颈动脉和股动脉内膜中层厚度与慢性肾脏病患者动脉粥样硬化组织病理学分级的关系。
Nephron. 2018;139(2):159-169. doi: 10.1159/000487491. Epub 2018 Mar 7.

引用本文的文献

1
In chronic kidney disease altered cardiac metabolism precedes cardiac hypertrophy.在慢性肾脏疾病中,心脏代谢的改变先于心脏肥大。
Am J Physiol Renal Physiol. 2024 May 1;326(5):F751-F767. doi: 10.1152/ajprenal.00416.2023. Epub 2024 Feb 22.
2
PTZ-kindled rat model; evaluation of seizure, hippocampal EGR-1, and Rev-erbα gene regulation, behavioral analysis, and antioxidant capacity of Gum Arabic.匹鲁卡品点燃大鼠模型;评价癫痫发作、海马 EGR-1 和 Rev-erbα 基因调控、行为分析和阿拉伯胶的抗氧化能力。
Mol Biol Rep. 2024 Feb 7;51(1):279. doi: 10.1007/s11033-024-09210-4.
3
Serum levels of Activin A: Marker of insulin resistance and cardiovascular risk in prediabetics.激活素A血清水平:糖尿病前期胰岛素抵抗和心血管风险的标志物。
J Family Med Prim Care. 2022 Oct;11(10):5983-5989. doi: 10.4103/jfmpc.jfmpc_128_22. Epub 2022 Oct 31.
4
Myostatin/Activin-A Signaling in the Vessel Wall and Vascular Calcification.血管壁中肌肉抑制素/激活素-A 信号转导与血管钙化。
Cells. 2021 Aug 12;10(8):2070. doi: 10.3390/cells10082070.

本文引用的文献

1
Associations of sclerostin with carotid artery atherosclerosis and all-cause mortality in Chinese patients undergoing maintenance hemodialysis.中国维持性血液透析患者中骨硬化蛋白与颈动脉粥样硬化及全因死亡率的关联。
BMC Nephrol. 2018 Oct 12;19(1):264. doi: 10.1186/s12882-018-1046-7.
2
Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.激活素 A 信号的系统激活导致慢性肾脏病-矿物质骨代谢紊乱。
Int J Mol Sci. 2018 Aug 23;19(9):2490. doi: 10.3390/ijms19092490.
3
Increased activin A levels in prediabetes and association with carotid intima-media thickness: a cross-sectional analysis from I-Lan Longitudinal Aging Study.在糖尿病前期中增加的激活素 A 水平与颈动脉内膜中层厚度的关系:一项来自宜兰纵向老化研究的横断面分析。
Sci Rep. 2018 Jul 2;8(1):9957. doi: 10.1038/s41598-018-27795-2.
4
Current and potential therapeutic strategies for the management of vascular calcification in patients with chronic kidney disease including those on dialysis.慢性肾脏病患者(包括接受透析的患者)血管钙化管理的当前及潜在治疗策略。
Semin Dial. 2018 Sep;31(5):487-499. doi: 10.1111/sdi.12710. Epub 2018 May 7.
5
Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury.鉴定尿激活素 A 作为反映急性肾损伤严重程度的新型生物标志物。
Sci Rep. 2018 Mar 26;8(1):5176. doi: 10.1038/s41598-018-23564-3.
6
The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.在慢性肾脏病期间,激活素受体在骨骼、血管、心脏和肾脏中被刺激。
Kidney Int. 2018 Jan;93(1):147-158. doi: 10.1016/j.kint.2017.06.016. Epub 2017 Aug 23.
7
The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology.慢性肾脏病-矿物质与骨异常(CKD-MBD):病理生理学进展
Bone. 2017 Jul;100:80-86. doi: 10.1016/j.bone.2017.01.023. Epub 2017 Jan 22.
8
Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.慢性肾脏病-矿物质和骨异常中的血管钙化:磷酸盐、成纤维细胞生长因子23及α-klotho蛋白的作用
Bone. 2017 Jul;100:87-93. doi: 10.1016/j.bone.2016.11.012. Epub 2016 Nov 12.
9
Activin receptor IIA ligand trap in chronic kidney disease: 1 drug to prevent 2 complications-or even more?激活素受体 IIA 配体陷阱在慢性肾脏病中的作用:一种药物预防 2 种并发症——甚至更多?
Kidney Int. 2016 Jun;89(6):1180-2. doi: 10.1016/j.kint.2016.02.006.
10
Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease.激活素IIA型受体的配体陷阱可预防慢性肾病小鼠的血管疾病和肾纤维化。
Kidney Int. 2016 Jun;89(6):1231-43. doi: 10.1016/j.kint.2016.02.002. Epub 2016 Mar 11.